Home
dMed Biopharmaceutical Co. Ltd.

dMed Biopharmaceutical C... Market Share Analysis for May 2026

Caidya 是一家提供全套服务的全球化 CRO，通过我们个性化的合作关系、全球化的专业技能和知识分享，激发您全部的科学潜能。

Health > Biotechnology and Pharmaceuticals

Domaindmedglobal.com

Year Founded2016

Employees501 - 1000

Annual Revenue$200M - $500M

dMed Biopharmaceutical Co. Ltd.

dMed Biopharmaceutical Co. Ltd. (including company regionals)

dmedglobal.com

See more website traffic and engagement information

dMed Biopharmaceutical Co. Ltd. Revenue up to May 2026 is 200M - 500M

revenue generated by dMed Biopharmaceutical Co. Ltd. top domains

dMed Biopharmaceutical Co. Ltd. top domains revenue over 3 years

Revenue for dMed Biopharmaceutical Co. Ltd. top domains

dmedglobal.com200M - 500M

See more with Sales Intelligence

Total visits to dMed Biopharmaceutical Co. Ltd.'s top domains

Understand dMed Biopharmaceutical Co. Ltd. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in dMed Biopharmaceutical Co. Ltd.'s top domains

Analyze dMed Biopharmaceutical Co. Ltd. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on dMed Biopharmaceutical Co. Ltd.'s top domains

See how dMed Biopharmaceutical Co. Ltd. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

dMed Biopharmaceutical Co. Ltd. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by dMed Biopharmaceutical Co. Ltd.

These are the website technologies, by industry, used by dMed Biopharmaceutical Co. Ltd. top domains

Social (3)

Instagram

Advertising (1)

PubMatic

Content Management System (1)

Atlassian Cloud

Conversion & Analytics (1)

CNZZ

More Technologies

2

See all

News & Signals from dMed Biopharmaceutical Co. Ltd.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsDmedglobal receives financing of $100M in Series C.dMed, a Shangai, China-based clinical CRO, completed a US$100m Series C financing.

NewsDmedglobal acquired Target Health, Inc. on Jan 1st '19.In 2019, dMed completed the acquisition of Target Health, a full-service New York-based CRO, to further extend its global footprint and service offerings.

NewsDmedglobal partners with NMS Group.dMed has entered a strategic collaboration with NMS Group at early stage of the project, providing a customized and integrated clinical development services for NMS Group to enter the Chinese market, and delivering high-quality results to accelerate the clinical trials process.